What's in Jennifer Holder-Murray's pipeline?

Jennifer Holder-Murray has 3 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Jennifer Holder-Murray's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jennifer-holder-murray.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Jennifer Holder-Murray — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jennifer Holder-Murray pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Area
Regional Block 2: QL1	Regional Block 2: QL1	phase 3	Anesthesiology
Neuraxial Analgesia	Neuraxial Analgesia	phase 3	Anesthesiology
Regional Block 1: Paravertebral	Regional Block 1: Paravertebral	phase 3	Anesthesia/Pain Management

Therapeutic area mix

Anesthesiology · 2
Anesthesia/Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Jennifer Holder-Murray:

Cite this brief

Drug Landscape (2026). Jennifer Holder-Murray — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jennifer-holder-murray. Accessed 2026-05-16.